EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Cell therapy comparison of dental pulp stem cells, hepatocytes, and their exosomes for liver fibrosis treatment in rats

Sahar Rahimi iD, Seyedeh Mahdieh Khoshnazar, Ali Derakhshani, Nader Shahrokhi

Animal Models and Experimental Medicine · 2026-07 · 9 (7) · 1436-1453

DOI: 10.1002/ame2.70207 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 09.06.2026. Verfasst von Sahar Rahimi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran. Hauptthemen laut MEDLINE: Exosomes, Dental Pulp, Hepatocytes, Liver Cirrhosis. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Physiology Research Center and the Department of Physiology, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Excessive extracellular matrix accumulation, primarily as a result of hepatic stellate cell activation, is a hallmark of hepatic fibrosis, a progressive outcome of chronic liver injuries. Recent research studies suggest that stem cells, hepatocytes, and extracellular vesicles may provide therapeutic advantages due to their anti‐inflammatory, antioxidative, and regenerative activities. This study aimed to comparatively evaluate the therapeutic efficacy of these agents in a rat model of carbon tetrachloride (CCl 4 )–induced hepatic fibrosis.

Methods

Liver fibrosis was induced in male Wistar rats via intraperitoneal CCl 4 injections for 8 weeks. Then the animals were intravenously administrated stem cells, hepatocytes, hepatocyte‐derived exosomes, or stem cell–derived exosomes. Also, a fibrosis, a sham, a intact, and a PBS‐treated group were consider the controls. After treatment, protein expression (alpha‐smooth muscle actin (α‐SMA), desmin), oxidative stress markers (superoxide dismutase, glutathione peroxidase, malondialdehyde), serum biochemical parameters (aspartate aminotransferase, alanine aminotransferase, glucose, uric acid, cholesterol, triglycerides), and fibrosis‐related gene expression (matrix metalloproteinase 2 (MMP2) , platelete‐derived growth factor receptor beta ( PDGFRB ), transforming growth factor‐beta ( TGF‐β ), thymosin beta‐10 ( TMSB10) and transmembrane protein 176B (TMEM176B) ) were assessed.

Results

Significant liver damage, changed metabolic parameters, increased oxidative stress, and upregulated fibrosis markers were all observed in the fibrosis group. On the contrary, all treatments caused considerable improvements, though exosomes derived from stem cells demonstrated the most significant effects. Along with improved histopathological features, this group exhibited significant decreases in oxidative damage, liver enzymes, and profibrotic marker expression.

Conclusion

Liver fibrosis was considerably reduced by stem cells, hepatocytes, and particularly their exosomes. Exosomes made from stem cells demonstrated the strongest therapeutic effect, confirming their potential as a viable noncellular hepatic fibrosis treatment approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesDental PulpHepatocytesLiver CirrhosisStem CellsCell- and Tissue-Based TherapyStem Cell TransplantationAnimalsMaleRats, WistarRatsOxidative StressCarbon Tetrachloride

Stichwörter der Autor:innen

CCl4dental pulp stem cellsexosomeshepatocytesliver fibrosisstem cells

Substanzen

Carbon Tetrachloride

Autor:innen und Institutionen

  • Department of Physiology and Pharmacology, Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran.
  • Clinical Research Development Unit, Shahid Bahonar Hospital, Kerman University of Medical Sciences, Kerman, Iran.
  • Research Center for Hydatid Disease in Iran, Kerman University of Medical Sciences, Kerman, Iran.

ORCID-Profile: Sahar Rahimi

Förderung

  • Physiology Research Center and the Department of Physiology, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Zitieren

APA

Rahimi, S., Khoshnazar, S. M., Derakhshani, A., & Shahrokhi, N. (2026). Cell therapy comparison of dental pulp stem cells, hepatocytes, and their exosomes for liver fibrosis treatment in rats. Animal Models and Experimental Medicine, 9(7), 1436-1453. https://doi.org/10.1002/ame2.70207

Vancouver

Rahimi S, Khoshnazar SM, Derakhshani A, Shahrokhi N. Cell therapy comparison of dental pulp stem cells, hepatocytes, and their exosomes for liver fibrosis treatment in rats. Animal Models and Experimental Medicine. 2026;9(7):1436-1453. doi:10.1002/ame2.70207

BibTeX
@article{Rahimi2026,
  author = {Rahimi, Sahar and Khoshnazar, Seyedeh Mahdieh and Derakhshani, Ali and Shahrokhi, Nader},
  title = {Cell therapy comparison of dental pulp stem cells, hepatocytes, and their exosomes for liver fibrosis treatment in rats},
  journal = {Animal Models and Experimental Medicine},
  year = {2026},
  volume = {9},
  number = {7},
  pages = {1436--1453},
  doi = {10.1002/ame2.70207}
}
Kostenlos starten →